Christine Konradi
Last active: 3/14/2018

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Mitochondrial DNA depletion by ethidium bromide decreases neuronal mitochondrial creatine kinase: Implications for striatal energy metabolism. Warren EB, Aicher AE, Fessel JP, Konradi C (2017) PLoS One 12(12): e0190456
    › Primary publication · 29287112 (PubMed) · PMC5747477 (PubMed Central)
  2. Polymerase gamma in bipolar disorder: It's complicated. Konradi C (2017) Psychiatry Clin Neurosci 71(8): 507
    › Primary publication · 28776861 (PubMed)
  3. Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques. Napolitano F, Booth Warren E, Migliarini S, Punzo D, Errico F, Li Q, Thiolat ML, Vescovi AL, Calabresi P, Bezard E, Morelli M, Konradi C, Pasqualetti M, Usiello A (2017) PLoS One 12(7): e0181677
    › Primary publication · 28742811 (PubMed) · PMC5526584 (PubMed Central)
  4. Role of mitochondria and energy metabolism in schizophrenia and psychotic disorders. Konradi C, Öngür D (2017) Schizophr Res : 1-2
    › Primary publication · 28705531 (PubMed)
  5. Effect of psychotropic drug treatment on sterol metabolism. Korade Ž, Liu W, Warren EB, Armstrong K, Porter NA, Konradi C (2017) Schizophr Res : 74-81
    › Primary publication · 28202290 (PubMed) · PMC5554466 (PubMed Central)
  6. GABAergic mechanisms of hippocampal hyperactivity in schizophrenia. Heckers S, Konradi C (2015) Schizophr Res 167(1-3): 4-11
    › Primary publication · 25449711 (PubMed) · PMC4402105 (PubMed Central)
  7. Substantia nigra hyperactivity in schizophrenia. Heckers S, Konradi C (2013) Biol Psychiatry 74(2): 82-3
    › Primary publication · 23809261 (PubMed)
  8. Expression and function of dopamine receptors in the developing medial frontal cortex and striatum of the rat. Sillivan SE, Konradi C (2011) Neuroscience : 501-14
    › Primary publication · 22015925 (PubMed) · PMC3253459 (PubMed Central)
  9. Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Wang AY, Lohmann KM, Yang CK, Zimmerman EI, Pantazopoulos H, Herring N, Berretta S, Heckers S, Konradi C (2011) Acta Neuropathol 122(5): 615-26
    › Primary publication · 21968533 (PubMed) · PMC4207060 (PubMed Central)
  10. Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia. Ohlin KE, Francardo V, Lindgren HS, Sillivan SE, O'Sullivan SS, Luksik AS, Vassoler FM, Lees AJ, Konradi C, Cenci MA (2011) Brain 134(Pt 8): 2339-57
    › Primary publication · 21771855 (PubMed) · PMC3155708 (PubMed Central)
  11. Hippocampal interneurons are abnormal in schizophrenia. Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S (2011) Schizophr Res 131(1-3): 165-73
    › Primary publication · 21745723 (PubMed) · PMC3159834 (PubMed Central)
  12. Binge cocaine administration in adolescent rats affects amygdalar gene expression patterns and alters anxiety-related behavior in adulthood. Sillivan SE, Black YD, Naydenov AV, Vassoler FR, Hanlin RP, Konradi C (2011) Biol Psychiatry 70(6): 583-92
    › Primary publication · 21571252 (PubMed) · PMC3159046 (PubMed Central)
  13. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Knoll AT, Muschamp JW, Sillivan SE, Ferguson D, Dietz DM, Meloni EG, Carroll FI, Nestler EJ, Konradi C, Carlezon WA (2011) Biol Psychiatry 70(5): 425-33
    › Primary publication · 21531393 (PubMed) · PMC3150294 (PubMed Central)
  14. Hippocampal pathology in schizophrenia. Heckers S, Konradi C (2010) Curr Top Behav Neurosci : 529-53
    › Primary publication · 21312412 (PubMed)
  15. Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Konradi C, Sillivan SE, Clay HB (2012) Neurobiol Dis 45(1): 37-47
    › Primary publication · 21310238 (PubMed) · PMC3117935 (PubMed Central)
  16. Myelin, copper, and the cuprizone model of schizophrenia. Herring NR, Konradi C (2011) Front Biosci (Schol Ed) : 23-40
    › Primary publication · 21196354 (PubMed) · PMC3058516 (PubMed Central)
  17. Hippocampal interneurons in bipolar disorder. Konradi C, Zimmerman EI, Yang CK, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S (2011) Arch Gen Psychiatry 68(4): 340-50
    › Primary publication · 21135314 (PubMed) · PMC3197787 (PubMed Central)
  18. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Clay HB, Sillivan S, Konradi C (2011) Int J Dev Neurosci 29(3): 311-24
    › Primary publication · 20833242 (PubMed) · PMC3010320 (PubMed Central)
  19. Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia. Naydenov AV, Vassoler F, Luksik AS, Kaczmarska J, Konradi C (2010) Acta Neuropathol 120(5): 623-31
    › Primary publication · 20740286 (PubMed) · PMC2955799 (PubMed Central)
  20. Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Cenci MA, Konradi C (2010) Prog Brain Res : 209-33
    › Primary publication · 20696322 (PubMed) · PMC2930606 (PubMed Central)
  21. Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats. Gregg JR, Herring NR, Naydenov AV, Hanlin RP, Konradi C (2009) Schizophr Res 113(2-3): 277-87
    › Primary publication · 19570651 (PubMed) · PMC2768476 (PubMed Central)
  22. Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Chartoff EH, Papadopoulou M, MacDonald ML, Parsegian A, Potter D, Konradi C, Carlezon WA (2009) Mol Pharmacol 75(3): 704-12
    › Primary publication · 19106229 (PubMed) · PMC2684917 (PubMed Central)
  23. Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Schroeder FA, Penta KL, Matevossian A, Jones SR, Konradi C, Tapper AR, Akbarian S (2008) Neuropsychopharmacology 33(12): 2981-92
    › Primary publication · 18288092 (PubMed) · PMC2746694 (PubMed Central)
  24. Isolation rearing impairs wound healing and is associated with increased locomotion and decreased immediate early gene expression in the medial prefrontal cortex of juvenile rats. Levine JB, Leeder AD, Parekkadan B, Berdichevsky Y, Rauch SL, Smoller JW, Konradi C, Berthiaume F, Yarmush ML (2008) Neuroscience 151(2): 589-603
    › Primary publication · 18063315 (PubMed) · PMC3923447 (PubMed Central)
  25. Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Westin JE, Vercammen L, Strome EM, Konradi C, Cenci MA (2007) Biol Psychiatry 62(7): 800-10
    › Primary publication · 17662258 (PubMed) · PMC4205578 (PubMed Central)
  26. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Naydenov AV, MacDonald ML, Ongur D, Konradi C (2007) Arch Gen Psychiatry 64(5): 555-64
    › Primary publication · 17485607 (PubMed)
  27. Isolation rearing and hyperlocomotion are associated with reduced immediate early gene expression levels in the medial prefrontal cortex. Levine JB, Youngs RM, MacDonald ML, Chu M, Leeder AD, Berthiaume F, Konradi C (2007) Neuroscience 145(1): 42-55
    › Primary publication · 17239545 (PubMed)
  28. Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell. Todtenkopf MS, Parsegian A, Naydenov A, Neve RL, Konradi C, Carlezon WA (2006) J Neurosci 26(45): 11665-9
    › Primary publication · 17093088 (PubMed) · PMC4205583 (PubMed Central)
  29. Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence. Black YD, Maclaren FR, Naydenov AV, Carlezon WA, Baxter MG, Konradi C (2006) J Neurosci 26(38): 9656-65
    › Primary publication · 16988036 (PubMed) · PMC4203339 (PubMed Central)
  30. Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. Youngs RM, Chu MS, Meloni EG, Naydenov A, Carlezon WA, Konradi C (2006) J Neurosci 26(22): 6031-9
    › Primary publication · 16738246 (PubMed) · PMC4205587 (PubMed Central)
  31. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C (2006) Bipolar Disord 8(3): 255-64
    › Primary publication · 16696827 (PubMed) · PMC4208624 (PubMed Central)
  32. Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Konradi C (2005) Brain Res Brain Res Rev 50(1): 142-55
    › Primary publication · 15964635 (PubMed)
  33. Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. MacDonald ML, Eaton ME, Dudman JT, Konradi C (2005) Biol Psychiatry 57(9): 1041-51
    › Primary publication · 15860345 (PubMed) · PMC2734482 (PubMed Central)
  34. L-type Ca2+ channel blockers promote Ca2+ accumulation when dopamine receptors are activated in striatal neurons. Eaton ME, Macías W, Youngs RM, Rajadhyaksha A, Dudman JT, Konradi C (2004) Brain Res Mol Brain Res 131(1-2): 65-72
    › Primary publication · 15530653 (PubMed) · PMC4203344 (PubMed Central)
  35. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA (2004) Neurobiol Dis 17(2): 219-36
    › Primary publication · 15474360 (PubMed) · PMC4208672 (PubMed Central)
  36. Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Carlezon WA, Konradi C (2004) Neuropharmacology : 47-60
    › Primary publication · 15464125 (PubMed) · PMC4204484 (PubMed Central)
  37. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S (2004) J Neurochem 90(5): 1117-31
    › Primary publication · 15312167 (PubMed) · PMC4203323 (PubMed Central)
  38. Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus. Benes FM, Burke RE, Walsh J, Berretta S, Matzilevich D, Minns M, Konradi C (2004) Mol Psychiatry 9(10): 932-45, 895
    › Primary publication · 15170462 (PubMed)
  39. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S (2004) Arch Gen Psychiatry 61(3): 300-8
    › Primary publication · 14993118 (PubMed)
  40. Effects of naloxone-precipitated morphine withdrawal on glutamate-mediated signaling in striatal neurons in vitro. Chartoff EH, Papadopoulou M, Konradi C, Carlezon WA (2003) Ann N Y Acad Sci : 368-71
    › Primary publication · 14684463 (PubMed)
  41. Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. Dudman JT, Eaton ME, Rajadhyaksha A, Macías W, Taher M, Barczak A, Kameyama K, Huganir R, Konradi C (2003) J Neurochem 87(4): 922-34
    › Primary publication · 14622123 (PubMed) · PMC4203348 (PubMed Central)
  42. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. Chartoff EH, Papadopoulou M, Konradi C, Carlezon WA (2003) J Neurochem 87(1): 107-18
    › Primary publication · 12969258 (PubMed) · PMC4205588 (PubMed Central)
  43. Striatal proenkephalin gene induction: coordinated regulation by cyclic AMP and calcium pathways. Konradi C, Macías W, Dudman JT, Carlson RR (2003) Brain Res Mol Brain Res 115(2): 157-61
    › Primary publication · 12877986 (PubMed) · PMC4205580 (PubMed Central)
  44. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Konradi C, Heckers S (2003) Pharmacol Ther 97(2): 153-79
    › Primary publication · 12559388 (PubMed) · PMC4203361 (PubMed Central)
  45. Analysis of DNA-binding activity in neuronal tissue with the electrophoretic mobility-shift assay. Konradi CL (2003) Methods Mol Med : 315-27
    › Primary publication · 12506706 (PubMed)
  46. Quantification of protein in brain tissue by western immunoblot analysis. Konradi CL (2003) Methods Mol Med : 263-71
    › Primary publication · 12506702 (PubMed)
  47. Quantification of mRNA in neuronal tissue by northern analysis. Konradi CL (2003) Methods Mol Med : 161-79
    › Primary publication · 12506696 (PubMed)
  48. Hippocampal neurons in schizophrenia. Heckers S, Konradi C (2002) J Neural Transm (Vienna) 109(5-6): 891-905
    › Primary publication · 12111476 (PubMed) · PMC4205576 (PubMed Central)
  49. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. Andersson M, Konradi C, Cenci MA (2001) J Neurosci 21(24): 9930-43
    › Primary publication · 11739600 (PubMed) · PMC4204657 (PubMed Central)
  50. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Konradi C, Heckers S (2001) Biol Psychiatry 50(10): 729-42
    › Primary publication · 11720691 (PubMed) · PMC4205586 (PubMed Central)
  51. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA (2001) J Neurosci 21(18): 7397-403
    › Primary publication · 11549750 (PubMed) · PMC4205577 (PubMed Central)
  52. Potassium chloride depolarization mediates CREB phosphorylation in striatal neurons in an NMDA receptor-dependent manner. Macías W, Carlson R, Rajadhyaksha A, Barczak A, Konradi C (2001) Brain Res 890(2): 222-32
    › Primary publication · 11164788 (PubMed) · PMC4203340 (PubMed Central)
  53. Intracellular modulation of NMDA receptor function by antipsychotic drugs. Leveque JC, Macías W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, Li XM, Coyle JT, Huganir RL, Heckers S, Konradi C (2000) J Neurosci 20(11): 4011-20
    › Primary publication · 10818136 (PubMed) · PMC4203343 (PubMed Central)
  54. Anatomic and molecular principles of psychopharmacology. A primer for psychiatrists. Heckers S, Konradi C (2000) Child Adolesc Psychiatr Clin N Am 9(1): 1-22
    › Primary publication · 10674188 (PubMed)
  55. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. Berger UV, Luthi-Carter R, Passani LA, Elkabes S, Black I, Konradi C, Coyle JT (1999) J Comp Neurol 415(1): 52-64
    › Primary publication · 10540357 (PubMed)
  56. L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. Rajadhyaksha A, Barczak A, Macías W, Leveque JC, Lewis SE, Konradi C (1999) J Neurosci 19(15): 6348-59
    › Primary publication · 10414964 (PubMed) · PMC4204489 (PubMed Central)
  57. Molecular components of striatal plasticity: the various routes of cyclic AMP pathways. Rajadhyaksha A, Leveque J, Macías W, Barczak A, Konradi C (1998) Dev Neurosci 20(2-3): 204-15
    › Primary publication · 9691194 (PubMed) · PMC4205584 (PubMed Central)
  58. The molecular basis of dopamine and glutamate interactions in the striatum. Konradi C (1998) Adv Pharmacol : 729-33
    › Primary publication · 9328002 (PubMed)
  59. Analysis of DNA-Protein Interactions in the Nervous System Using the Electrophoretic Mobility Shift Assay Lewis SE, Konradi C (1996) Methods 10(3): 301-11
    › Primary publication · 8954842 (PubMed)
  60. Kainic acid induces apoptosis in neurons. Simonian NA, Getz RL, Leveque JC, Konradi C, Coyle JT (1996) Neuroscience 75(4): 1047-55
    › Primary publication · 8938740 (PubMed)
  61. Kainate induces apoptosis in neurons. Simonian NA, Getz RL, Leveque JC, Konradi C, Coyle JT (1996) Neuroscience 74(3): 675-83
    › Primary publication · 8884764 (PubMed)
  62. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. Konradi C, Leveque JC, Hyman SE (1996) J Neurosci 16(13): 4231-9
    › Primary publication · 8753884 (PubMed) · PMC4203342 (PubMed Central)
  63. Localization of juvenile, but not late-infantile, neuronal ceroid lipofuscinosis on chromosome 16. Yan W, Boustany RM, Konradi C, Ozelius L, Lerner T, Trofatter JA, Julier C, Breakefield XO, Gusella JF, Haines JL (1993) Am J Hum Genet 52(1): 89-95
    › Primary publication · 8434611 (PubMed) · PMC1682098 (PubMed Central)
  64. The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Konradi C, Kobierski LA, Nguyen TV, Heckers S, Hyman SE (1993) Proc Natl Acad Sci U S A 90(15): 7005-9
    › Primary publication · 8346209 (PubMed) · PMC47064 (PubMed Central)
  65. Molecular mechanisms of stress-induced proenkephalin gene regulation: CREB interacts with the proenkephalin gene in the mouse hypothalamus and is phosphorylated in response to hyperosmolar stress. Borsook D, Konradi C, Falkowski O, Comb M, Hyman SE (1994) Mol Endocrinol 8(2): 240-8
    › Primary publication · 8170480 (PubMed) · PMC4205567 (PubMed Central)
  66. Stress-induced regulation of a human proenkephalin-beta-galactosidase fusion gene in the hypothalamus of transgenic mice. Borsook D, Falkowski O, Burstein R, Strassman A, Konradi C, Dauber A, Comb M, Hyman SE (1994) Mol Endocrinol 8(1): 116-25
    › Primary publication · 8152426 (PubMed)
  67. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. Konradi C, Cole RL, Heckers S, Hyman SE (1994) J Neurosci 14(9): 5623-34
    › Primary publication · 8083758 (PubMed)
  68. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Cole DG, Kobierski LA, Konradi C, Hyman SE (1994) Proc Natl Acad Sci U S A 91(20): 9631-5
    › Primary publication · 7937819 (PubMed) · PMC44867 (PubMed Central)
  69. Pharmacologic regulation of striatal proenkephalin gene expression via transcription factor CREB. Hyman SE, Konradi C, Kobierski L, Cole R, Senatus P, Green D (1994) Prog Clin Biol Res : 155-71
    › Primary publication · 7724644 (PubMed)
  70. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Cole RL, Konradi C, Douglass J, Hyman SE (1995) Neuron 14(4): 813-23
    › Primary publication · 7718243 (PubMed) · PMC4207064 (PubMed Central)
  71. Analysis of the proenkephalin second messenger-inducible enhancer in rat striatal cultures. Konradi C, Cole RL, Green D, Senatus P, Leveque JC, Pollack AE, Grossbard SJ, Hyman SE (1995) J Neurochem 65(3): 1007-15
    › Primary publication · 7643080 (PubMed)
  72. Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein. Konradi C, Heckers S (1995) Neuroscience 65(4): 1051-61
    › Primary publication · 7617161 (PubMed)
  73. Dopamine regulation of transcription factor-target interactions in rat striatum. Hyman SE, Cole RL, Konradi C, Kosofsky BE (1995) Chem Senses 20(2): 257-60
    › Primary publication · 7583020 (PubMed)
  74. Histochemistry of MAO-A and MAO-B in the locus coeruleus of the Mongolian gerbil. Konradi C, Jellinger K, Riederer P, Nagatsu T (1987) J Neural Transm 70(3-4): 369-76
    › Primary publication · 3681291 (PubMed)
  75. Cellular action of MAO inhibitors. Konradi C, Riederer P, Jellinger K, Denney R (1987) J Neural Transm Suppl : 15-25
    › Primary publication · 3480938 (PubMed)
  76. Biochemical fundamentals of Parkinson's disease. Riederer P, Rausch WD, Schmidt B, Kruzik P, Konradi C, Sofić E, Danielczyk W, Fischer M, Ogris E (1988) Mt Sinai J Med 55(1): 21-8
    › Primary publication · 3279302 (PubMed)
  77. Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G (1988) Acta Psychiatr Scand 78(6): 730-6
    › Primary publication · 3223331 (PubMed)
  78. Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study. Konradi C, Riederer P, Youdim MB (1986) J Neural Transm Suppl : 61-73
    › Primary publication · 3097261 (PubMed)
  79. Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl. Riederer P, Konradi C, Schay V, Kienzl E, Birkmayer G, Danielczyk W, Sofic E, Youdim MB (1987) Adv Neurol : 111-8
    › Primary publication · 3030067 (PubMed)
  80. Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem. Konradi C, Svoma E, Jellinger K, Riederer P, Denney R, Thibault J (1988) Neuroscience 26(3): 791-802
    › Primary publication · 2904662 (PubMed)
  81. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Kornhuber J, Konradi C, Mack-Burkhardt F, Riederer P, Heinsen H, Beckmann H (1989) Brain Res 499(1): 81-6
    › Primary publication · 2804672 (PubMed)
  82. Isoelectric focusing of monoamine oxidase subtypes as identified by MAO inhibitors. Fritze J, Koronakis P, Konradi C, Riederer P (1989) Eur J Pharmacol 172(2): 147-54
    › Primary publication · 2767139 (PubMed)
  83. [Neurochemical perspectives of the function of monoamine oxidases]. Riederer P, Konradi C, Hebenstreit G (1989) Psychiatr Prax : 7-10
    › Primary publication · 2685857 (PubMed)
  84. Effect of antemortem and postmortem factors on [3H]MK-801 binding in the human brain: transient elevation during early childhood. Kornhuber J, Mack-Burkhardt F, Konradi C, Fritze J, Riederer P (1989) Life Sci 45(8): 745-9
    › Primary publication · 2674577 (PubMed)
  85. Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical technique. Konradi C, Kornhuber J, Froelich L, Fritze J, Heinsen H, Beckmann H, Schulz E, Riederer P (1989) Neuroscience 33(2): 383-400
    › Primary publication · 2622533 (PubMed)
  86. Neurochemical perspectives to the function of monoamine oxidase. Riederer P, Konradi C, Hebenstreit G, Youdim MB (1989) Acta Neurol Scand Suppl : 41-5
    › Primary publication · 2618592 (PubMed)
  87. The role of MAO in dopaminergic transmission. Riederer P, Konradi C, Youdim MB (1990) Adv Neurol : 149-53
    › Primary publication · 2173368 (PubMed)
  88. Dinucleotide repeat polymorphism (D16S285) on human chromosome 16. Konradi C, Ozelius L, Yan W, Gusella JF, Breakefield XO (1991) Nucleic Acids Res 19(19): 5449
    › Primary publication · 1923837 (PubMed) · PMC328929 (PubMed Central)
  89. Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB gene. Konradi C, Ozelius L, Breakefield XO (1992) Genomics 12(1): 176-7
    › Primary publication · 1733859 (PubMed)
  90. Variations of monoamines and their metabolites in the human brain putamen. Konradi C, Kornhuber J, Sofic E, Heckers S, Riederer P, Beckmann H (1992) Brain Res 579(2): 285-90
    › Primary publication · 1628216 (PubMed)
  91. Relationship between platelet monoamine oxidase B activity and alleles at the MAOB locus. Girmen AS, Baenziger J, Hotamisligil GS, Konradi C, Shalish C, Sullivan JL, Breakefield XO (1992) J Neurochem 59(6): 2063-6
    › Primary publication · 1431894 (PubMed)